However, preoperative IL-2 may need to be employed with caution as Li et al. demonstrated that preoperative IL-2 therapy increased surgically-induced Treg numbers and enhanced Treg function in patients receiving radical mastectomies, and with melanoma or renal cancers [132,141]. The gene discussed is IL2; the disease is melanoma.